Related Experiment Videos

Warfarin induced dermatitis and venous thrombosis in a patient with Protein S deficiency

R Quintavalla1, M Pini, C Manotti

  • 1V Divisione Medica e Centro per le Malattie Emostatiche, Ospedale Regionale, Parma, Italy.

Insights

Warfarin-induced dermatitis occurred in a patient with Protein S deficiency. Treatment involved stopping warfarin, initiating heparin, and resulted in improved skin lesions and normalized CPK levels.

Area of Science:

  • Cardiology
  • Dermatology
  • Hematology

Background:

  • Protein S deficiency is a risk factor for venous thromboembolism.
  • Warfarin is a common anticoagulant used to prevent blood clots.

Observation:

  • A 79-year-old patient with Protein S deficiency developed warfarin-induced dermatitis.
  • The patient presented with skin lesions, elevated creatine phosphokinase (CPK) levels, and deep vein thrombosis.

Findings:

  • Both total and free Protein S levels were reduced by approximately 50%.
  • The skin lesions did not progress to necrosis.
  • Warfarin withdrawal and heparin therapy led to rapid normalization of CPK and improvement of skin lesions.

Implications:

  • This case highlights the potential complication of warfarin-induced skin necrosis in patients with Protein S deficiency.
  • Early recognition and management, including switching to heparin, are crucial for favorable outcomes.
  • Understanding the interplay between anticoagulation, protein S levels, and dermatological reactions is important for clinical practice.

Related Concept Videos